<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02020382</url>
  </required_header>
  <id_info>
    <org_study_id>P120903</org_study_id>
    <secondary_id>2013-A00310-45</secondary_id>
    <nct_id>NCT02020382</nct_id>
  </id_info>
  <brief_title>Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Diseases</brief_title>
  <acronym>MicroMICI</acronym>
  <official_title>Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the diagnostic value of microRNAs in IBD colon&#xD;
      (ulcerative colitis or Crohn's disease) in adults as compared to healthy controls (and&#xD;
      non-IBD colitis)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RATIONAL Inflammatory Bowel Disease (IBD) affects more than 200,000 people in France and 1.5&#xD;
      million in Europe. Difficulties in the management of IBD are related to the need for invasive&#xD;
      tests for the diagnosis of IBD (endoscopy), partly explaining the delay in diagnosis, and the&#xD;
      inability to distinguish early colonic Crohn's disease of ulcerative colitis (UC) in 10-30%&#xD;
      of cases.&#xD;
&#xD;
      Recently, we identified real-time polymerase chain reaction (PCR), from healthy colonic&#xD;
      mucosa of IBD patients, a molecular signature of IBD involving 10 microRNA (miRNA) Common&#xD;
      (miR26a, miR29a, miR29b, miR126 * miR15a, miR127-3p, miR324 -3p, miR30c, miR185, miR196a) and&#xD;
      15 colic chronic disease (MC) and ulcerative colitis (RCH) discriminating microRNA&#xD;
      (miR-142-3p, miR-142-5p, miR-146a, miR-146b-5p, miR150, miR-181d, miR-182, miR199a -3p,&#xD;
      miR199a-5p, miR199b-5p, miR-203, miR223, miR-299-5p, miR320a, miR-328).&#xD;
&#xD;
      TYPE OF STUDY : multicenter diagnostic evaluation Study&#xD;
&#xD;
      MAIN PURPOSE OF THE STUDY : To evaluate the diagnostic value of microRNA in colonic IBD&#xD;
      (ulcerative colitis or Crohn's disease) in adults as compared to healthy controls (and&#xD;
      non-IBD colitis)&#xD;
&#xD;
      SECONDARY OBJECTIVES :&#xD;
&#xD;
        -  assess the ability of microRNA to discriminate a colic chronic disease (MC) of&#xD;
           ulcerative colitis (RCH) in adults&#xD;
&#xD;
        -  evaluate the diagnostic value of microRNA in inflammatory colitis child&#xD;
&#xD;
        -  explore the possibility of measuring miRNA of interest in the stool&#xD;
&#xD;
      PRODUCTS OF THE STUDY diagnostic kit of IBD in quantitative polymerase chain reaction (qPCR)&#xD;
&#xD;
      NUMBER OF PATIENTS : 6 groups of 50 patients each will be included&#xD;
&#xD;
        -  Group 1: Crohn adult colic&#xD;
&#xD;
        -  Group 2: ulcerative colitis (RCH) adults&#xD;
&#xD;
        -  Group 3: Witnesses healthy adults&#xD;
&#xD;
        -  Group 4: Witnesses adults with non-IBD inflammation&#xD;
&#xD;
        -  Group 5: Children with colitis&#xD;
&#xD;
        -  Group 6 : Witnesses healthy children&#xD;
&#xD;
      INCLUSION LENGTH 30 months&#xD;
&#xD;
      DURATION OF THE STUDY 30 months&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the diagnostic value of microRNAs in qPCR,in IBD colon (ulcerative colitis or Crohn's disease) in adults compared to health</measure>
    <time_frame>1 day</time_frame>
    <description>Evaluate the diagnostic value of microRNAs in qPCR, suitable for routine use, initially testing the expression of 25 miRNAs from endoscopic biopsies in IBD colon (ulcerative colitis or Crohn's disease) in adults compared to health</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>- Evaluate the ability of miRNAs to discriminate a MC colic of UC in adults</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the diagnostic value of microRNAs in inflammatory colitis child</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Study the possibility of measuring miRNA of interest in feces and saliva</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">325</enrollment>
  <condition>Ulcerative Colitis</condition>
  <condition>Crohn Disease</condition>
  <condition>Healthy</condition>
  <condition>Non-IBD Colitis</condition>
  <arm_group>
    <arm_group_label>Crohn adult colic</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>testing qPCR diagnostic KIT of microRNAS from colonic biopsies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RCH adults</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>testing qPCR diagnostic KIT of microRNAS from colonic biopsies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Witnesses healthy adults</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>testing qPCR diagnostic KIT of microRNAS from colonic biopsies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Witnesses adults with non-IBD inflammation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>testing qPCR diagnostic KIT of microRNAS from colonic biopsies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Children with colitis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>testing qPCR diagnostic KIT of microRNAS from colonic biopsies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Witnesses healthy children</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>testing qPCR diagnostic KIT of microRNAS from colonic biopsies</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>qPCR diagnostic KIT of microRNAS</intervention_name>
    <description>testing qPCR diagnostic KIT of microRNAS from colonic biopsies</description>
    <arm_group_label>Children with colitis</arm_group_label>
    <arm_group_label>Crohn adult colic</arm_group_label>
    <arm_group_label>RCH adults</arm_group_label>
    <arm_group_label>Witnesses adults with non-IBD inflammation</arm_group_label>
    <arm_group_label>Witnesses healthy adults</arm_group_label>
    <arm_group_label>Witnesses healthy children</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria :&#xD;
&#xD;
          -  Target Population : Patients (children and adults), man or woman, suffering from&#xD;
             Crohn's disease with colonic involvement or ulcerative colitis according to the&#xD;
             criteria of the European consensus (ECCO 2010)&#xD;
&#xD;
          -  Control population: healthy subjects and any non-Crohn's colitis or ulcerative colitis&#xD;
&#xD;
          -  Having a colonoscopy examination indication,&#xD;
&#xD;
          -  Who signed the consent form (for adults and signed parental consent obtained for&#xD;
             patients minors)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No health insurance ,&#xD;
&#xD;
          -  mental disability,&#xD;
&#xD;
          -  pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xavier Treton, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Beaujon</name>
      <address>
        <city>Clichy</city>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Louis</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Necker Enfants Malades</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Robert Deré</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>December 9, 2013</study_first_submitted>
  <study_first_submitted_qc>December 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2013</study_first_posted>
  <last_update_submitted>May 18, 2018</last_update_submitted>
  <last_update_submitted_qc>May 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>microRNAs</keyword>
  <keyword>IBD</keyword>
  <keyword>Crohn's disease</keyword>
  <keyword>Ulcerative colitis</keyword>
  <keyword>colonic polyps screening</keyword>
  <keyword>controls</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

